{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:44:53Z","timestamp":1772577893216,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.jpeds.2010.09.013","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T04:24:39Z","timestamp":1288326279000},"page":"433-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Growth Hormone Excess in Children with Neurofibromatosis Type 1-Associated and Sporadic Optic Pathway Tumors"],"prefix":"10.1016","volume":"158","author":[{"given":"Jami","family":"Josefson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Listernick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason R.","family":"Fangusaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Charrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reema","family":"Habiby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2010.09.013_bib1","first-page":"2730","article-title":"Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group","volume":"83","author":"Orme","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2010.09.013_bib2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1469-8749.1983.tb13774.x","article-title":"Optic gliomata affecting twins with neurofibromatosis","volume":"25","author":"Crawford","year":"1983","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jpeds.2010.09.013_bib3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ana.410150318","article-title":"Hypothalamic mass and gigantism in neurofibromatosis: treatment with bromocriptine","volume":"15","author":"Duchowny","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpeds.2010.09.013_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3171\/jns.1994.81.4.0595","article-title":"Optic pathway glioma infiltrating into somatostatinergic pathways in a young boy with gigantism. Case report","volume":"81","author":"Manski","year":"1994","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jpeds.2010.09.013_bib5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/000992289803701207","article-title":"Growth hormone excess in a child with neurofibromatosis type 1 and optic pathway tumor: a patient report","volume":"37","author":"Fuqua","year":"1998","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jpeds.2010.09.013_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2265.2000.01041.x","article-title":"Gigantism due to growth hormone excess in a boy with optic glioma","volume":"53","author":"Drimmie","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jpeds.2010.09.013_bib7","first-page":"1","article-title":"Pegvisomant treatment in a 4-year-old girl with neurofibromatosis type 1","volume":"65","author":"Main","year":"2006","journal-title":"Horm Res"},{"key":"10.1016\/j.jpeds.2010.09.013_bib8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-3476(95)70449-3","article-title":"Precocious puberty in children with neurofibromatosis type 1","volume":"126","author":"Habiby","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2010.09.013_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0887-8994(00)00123-5","article-title":"Growth hormone deficiency in children with neurofibromatosis type 1 without suprasellar lesions","volume":"22","author":"Vassilopoulou-Sellin","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jpeds.2010.09.013_bib10","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1093\/hmg\/ddn194","article-title":"Lee da Y, Emnett RJ, Li J, Gutmann DH. Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis","volume":"17","author":"Hegedus","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jpeds.2010.09.013_bib11","first-page":"895","article-title":"Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysis","volume":"141","author":"Lloyd","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jpeds.2010.09.013_bib12","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3476(89)80137-4","article-title":"Optic gliomas in children with neurofibromatosis type 1","volume":"114","author":"Listernick","year":"1989","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2010.09.013_bib13","first-page":"1","article-title":"Neurofibromatosis","volume":"6","year":"1987","journal-title":"Natl Inst Health Consens Dev Conf Consens Statement"},{"key":"10.1016\/j.jpeds.2010.09.013_bib14","first-page":"3539","article-title":"Diagnostic value of fluorometric assays in the evaluation of precocious puberty","volume":"84","author":"Brito","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2010.09.013_bib15","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1210\/jc.2007-1244","article-title":"Growth hormone suppression after an oral glucose load in children","volume":"92","author":"Misra","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2010.09.013_bib16","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1210\/jc.2006-0656","article-title":"Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor","volume":"91","author":"Ergun-Longmire","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2010.09.013_bib17","first-page":"4444","article-title":"Growth hormone treatment of children with brain tumors and risk of tumor recurrence","volume":"85","author":"Swerdlow","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2010.09.013_bib18","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0022-3476(96)70002-1","article-title":"Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience","volume":"128","author":"Moshang","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2010.09.013_bib19","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1210\/jc.2005-2347","article-title":"Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage","volume":"91","author":"Cozzi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2010.09.013_bib20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM200004203421604","article-title":"Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant","volume":"342","author":"Trainer","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2010.09.013_bib21","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1210\/jc.2007-2283","article-title":"Treatment of pituitary gigantism with the growth hormone receptor antagonist pegvisomant","volume":"93","author":"Goldenberg","year":"2008","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347610007730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347610007730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:54:00Z","timestamp":1758358440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347610007730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0022347610007730"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2010.09.013","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth Hormone Excess in Children with Neurofibromatosis Type 1-Associated and Sporadic Optic Pathway Tumors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2010.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}